Gallium Ga 68-DOTATATE: Clinical Trials

5 trials of Gallium Ga 68-DOTATATE, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 1 completed. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Recruiting 4, Completed 1
Phase 11Recruiting 1

Follow Gallium Ga 68-DOTATATE: new trials by email Literature Review of Gallium Ga 68-DOTATATE trials Research Report on Gallium Ga 68-DOTATATE

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer
Biopsy, Biospecimen Collection, Computed Tomography - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 2RecruitingOHSU Knight Cancer Institute102026-06-302026-06-05
RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
Actinium Ac 225 DOTATATE RYZ101, Biospecimen Collection, Computed Tomography - Recurrent Meningioma
Phase 1 / Phase 2RecruitingJoshua Palmer302025-11-122026-08-13
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
Biospecimen Collection, Computed Tomography, Gallium Ga 68-DOTATATE - Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic Prostate Neuroendocrine Carcinoma
Phase 2RecruitingNational Cancer Institute (NCI)352023-12-272026-11-03
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
Gallium Ga 68-DOTATATE, Lutetium Lu 177 Dotatate, Magnetic Resonance Imaging - Grade 1 Meningioma, Grade 2 Meningioma
Phase 2RecruitingMayo Clinic422020-04-142026-10-13
Gallium Ga 68-DOTATATE PET/CT in Diagnosing Patients With Metastatic Castration Resistant Prostate Cancer
CT (Computed Tomography), Gallium Ga 68-DOTATATE, Positron Emission Tomography - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 2CompletedEmory University172018-02-222025-07-17

Conditions studied

Meningioma (2)  ·  Prostatic Neoplasms (2)  ·  Breast Neoplasms (1)

Sponsors

Emory University (1)  ·  Joshua Palmer (1)  ·  Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)  ·  OHSU Knight Cancer Institute (1)

Countries

United States (5)

Top investigators

John M Floberg (1)  ·  Joshua D Palmer, MD (1)  ·  Kenneth W. Merrell, MD (1)  ·  Mehmet Asim Bilen, MD (1)  ·  Rodney F Pommier (1)

NIH funding

UM1CA186691 (1)